Baotou Tianhe Magnetics Technology
603072
HuangShan Googe
301581
Geovis Insighter Technology
920116
CHICHENG ELECTRIC
834407
Xdc Industries(Shenzhen)Limited
300615
CN Stock MarketDetailed Quotes
605199 Hainan Huluwa Pharmaceutical Group
- 17.49
- +1.59+10.00%
Market Closed Jan 3 15:00 CST
7.00BMarket Cap62.02P/E (TTM)
17.49High15.42Low321.04KlotVolume15.99Open15.90Pre Close534.47MTurnover8.02%Turnover Ratio65.75P/E (Static)400.11MShares25.1652wk High6.06P/B7.00BFloat Cap9.0952wk Low17.49Limit Up400.11MShs Float49.61Historical High14.31Limit Down13.02%Amplitude5.96Historical Low0.13Dividend TTM16.65Avg Price133.41KlotAsk0.71%Div YieldTTM100Lot Size176.02KlotBid
Hainan Huluwa Pharmaceutical Group News
Hainan Huluwa Pharmaceutical Unit Passes GMP Compliance Inspection
Express News | Hainan Huluwa Pharmaceutical Group: wholly-owned subsidiary Guangxi Weiwei Pharmaceutical passed the Pharmaceutical GMP compliance inspection.
Many high-priced A-shares have plummeted, with global top e-commerce and several other stocks hitting the daily limit down.
On December 9, Gelonghui reported that Global Top E-commerce, Hainan Huluwa Pharmaceutical Group, Fujian Zhangzhou Development, Tianjin Guifaxiang 18th Street Mahua Food, and other stocks hit the limit down.
The A-share hainan free trade zone sector weakened, with hainan huluwa pharmaceutical group hitting the down limit.
On December 6th, Gelonghui reported that hainan huluwa pharmaceutical group fell to the limit, with hainan development holdings nanhai, hainan drinda new energy technology, lanzhou lishang guochao industrial group, Gongxiao Daji, and hainan shuangcheng pharmaceuticals also declining.
High-position stocks opened collectively with a significant drop.
In the stock market on December 5th, Hainan Huluwa Pharmaceutical Group, Nanfang Black Sesame Group, Tianjin Guifaxiang 18th Street Mahua Food, and Fujian Zhangzhou Development all hit the limit down, while Yonghui Superstores, Taier Heavy Industry, Beijing Teamsun Technology, and Guangbo Group Stock opened significantly lower.
Express News | Hainan Huluwa Pharmaceutical Group, which has been continuously listed for 7 days, has a pe and pb higher than the industry average.
The A-share hainan sector opened high, and hainan huluwa pharmaceutical group achieved six consecutive boards.
Gelonghui December 3 | Hainan Huluwa Pharmaceutical Group has a six-day winning streak, Xinlong Holding(Group)Company, Honz Pharmaceutical, Caesar Travel, Canaan Ruize, and Hainan Expressway have all surged to the limit price, while Luoniushan Co., Ltd., Hainan Strait Shipping, and others opened collectively high.
The hainan huluwa pharmaceutical group (605199.SH) has had a significant short-term increase in stock prices, which may be due to irrational speculation.
Hainan Huluwa Pharmaceutical Group (605199.SH) has issued a risk warning announcement stating that the company's stock price has increased significantly in the short term, which may pose...
In November, the frenzy of "mystical stock trading" is in full swing, with the strongest bull stock experiencing 15 daily limit-ups in 20 days, trading Eastern related stocks, zodiac Snake related stocks, numerical series, etc...
Attention economy
Hainan Huluwa Pharmaceutical Group (605199.SH): There are no significant matters that should have been disclosed but were not disclosed.
On November 29, Gelonghui reported that hainan huluwa pharmaceutical group (605199.SH) announced that its stocks have been trading limit-up for four consecutive trading days from November 26, 2024, to November 29, 2024, with a cumulative increase of 46.40%. The cumulative turnover ratio over the past four trading days is 19.83%. The company especially reminds investors to pay attention to secondary market trading risks, make rational decisions, and invest cautiously. After the company's self-examination and written verification with the company's controlling shareholder and actual controller, as of the date of this announcement, there are no major matters that should be disclosed but have not been disclosed by the company.
Express News | Hainan huluwa pharmaceutical group: the company's pe and pb are higher than the industry average.
Express News | Hainan huluwa pharmaceutical group: There has been no significant change in the company's production and operation situation.
A-share concept stocks related to the three-child policy are rising, beingmate co.,ltd is pushing for a limit up.
On November 28, Gelonghui reported that beingmate co.,ltd hit the limit up, hainan huluwa pharmaceutical group and lafang china previously sealed the board, while Kidswant, shanghai aiyingshi, and jinfa labi maternity & baby articles also followed the rise.
Hainan Huluwa Pharmaceutical Group (605199.SH): Zhongjia Rui has cumulatively reduced its shareholding by 1.33%.
Glory Holdings announced on November 27 that hainan huluwa pharmaceutical group (605199.SH) received a notice from Zhongjiao Rui stating that the shareholding plan had been completed. From November 25 to November 26, 2024, Zhongjiao Rui reduced its shareholding by a total of 5,341,050 shares, accounting for 1.33% of the company's total share capital.
The A-share innovative drugs sector surged, hainan huluwa pharmaceutical group reached its maximum increase.
Greelonghui November 26th | Hainan Huluwa pharmaceutical group hit the limit up, Huayu Pharmaceutical rose more than 7%, Sailong Pharmaceutical Group, Betta Pharmaceuticals, Shanghai Allist Pharmaceuticals Co., Ltd., and others followed the upward trend.
Express News | hainan huluwa pharmaceutical group: The company and its subsidiaries have received a total of 10.6863 million yuan in government subsidies related to income.
Hainan Huluwa Pharmaceutical Group (605199.SH): Intends to change some of the raised funds investment projects.
Gelonghui November 11th | hainan huluwa pharmaceutical group (605199.SH) announced that the original 'pediatric pharmaceutical research and development' project includes three pharmaceutical research and development sub-projects: children's Ma Long cough and asthma granules, children's Huaji granules, children's pneumonia patches, etc. It is planned to invest 50 million yuan in the funds raised. As of October 31, 2024, a total of 20.1917 million yuan of the raised funds has been used, and the remaining uninvested raised funds balance is 30.5728 million yuan (including interest). Due to factors such as the relatively large difficulty in recruiting children for clinical trials of pediatric medicines, the research and development progress of the above pharmaceutical research and development projects lags behind the previous expectations.
Express News | Hainan Huluwa Pharmaceutical Group: obtained the registration certificate for oseltamivir phosphate capsules.
hainan huluwa pharmaceutical group (605199.SH) subsidiary guangxi viwei received pharmaceutical GMP compliance inspection results
Hainan Huluwa Pharmaceutical Group (605199.SH) announced that its wholly-owned subsidiary Guangxi Weiwei Pharmaceutical Co., Ltd. (hereinafter referred to as...
Hainan Huluwa Pharmaceutical Group (605199.SH) obtained the registration certificate for Acalabrutinib injection pharmaceutical.
Hainan Huluwa Pharmaceutical Group (605199.SH) announced that the company recently received approval issued by the National Medical Products Administration regarding...
